PMID: 41678931

Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors.

Kim Nayoung, Lukong Kiven Erique

Cancer treatment and research communications · 2026

Vol. 47, pp. 101134

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansAromatase InhibitorsFemaleBreast NeoplasmsUnited StatesUnited States Food and Drug AdministrationReceptors, EstrogenDrug ApprovalSelective Estrogen Receptor ModulatorsAntineoplastic Agents, Hormonal

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.